News Industry News Micell Technologies Announces Presentation of Clinical Data at TCT 2011 November 02, 2011
News Industry News Elixir Medical Corporation Announces Successful Completion of First-In-Man Study Enrollment for Fully Bioresorbable Drug Eluting Coronary Scaffold System November 02, 2011
News Industry News Boston Scientific Announces Schedule of Events at TCT Scientific Symposium November 01, 2011
News Industry News Abbott Receives U.S. FDA Approval for Next-Generation XIENCE PRIME™ Drug Eluting Stent November 01, 2011
News Daily News DES Shows Slight Edge Over BMS in Patients with Kidney Disease L.A. McKeown October 21, 2011
News Daily News First DES for Above-the-Knee Vascular Disease on the Horizon L.A. McKeown October 18, 2011
News Daily News Bivalirudin Decreases Bleeding Regardless of Heparin Anticoagulation Level Yael L. Maxwell October 13, 2011
News Daily News Study Proposes New CK-MB Threshold for Periprocedural MI Caitlin E. Cox October 12, 2011
News Industry News Boston Scientific Begins Clinical Trial Enrollment for OMEGA™ Platinum Chromium Stent System October 05, 2011
News Daily News Clinical Variables Added to Syntax Score Increases Predictive Ability L.A. McKeown September 30, 2011
News Daily News Model Tries to Simplify Choice Between Drug-Eluting, Bare-Metal Stents L.A. McKeown September 16, 2011
News Daily News Drug-Eluting Balloon Continues to Show Positive Results in SFA, Popliteal Disease Jason Kahn September 15, 2011
News Daily News Meta-analysis: Everolimus-Eluting Stents Reduce Thrombosis vs. Other DES September 14, 2011
News Daily News Long-term Outcomes Similar for Biodegradable-Polymer, Permanent-Polymer DES September 12, 2011
News Daily News ISAR-CABG Published: DES Preferred for Saphenous Vein Graft Lesions Jason Kahn September 12, 2011
News Daily News Drug-Eluting Balloons Show ‘Impressive’ Results in Below-the-Knee Lesions Jason Kahn September 08, 2011
News Conference News Two Trials Show Favorable Results with XIENCE V vs. Earlier DES, BMS September 02, 2011